Answers are grounded in this paper and cite their sources.
Review reveals shared pharmacotherapeutic properties of morinda citrifolia and lumbricus rubellus, suggesting potential in traditional Chinese medicine.
The ongoing challenge faced by Western medicine in effectively treating numerous human and animal diseases has become a pressing global concern due to the escalation of drug resistance and toxicity issues. Consequently, scientists are actively exploring better alternative options to combat these challenges. One promising avenue under exploration is the use of integrated traditional sources characterized by their easy availability, reduced toxicity, and cost-effectiveness. Therefore, the present review focuses on exploring the phytochemical composition and pharmacotherapeutic potential of two such sources; Morinda citrifolia (noni), a herbal plant, and Lumbricus rubellus (Red Earthworm), a parasite. Despite their distinct origins (botanical and zoological, respectively), they exhibit a range of shared pharmacotherapeutic properties including antioxidant, anti-inflammatory, antimicrobial, antihypertensive, and antidiabetic effects. These properties, coupled with their clinical safety profiles, pose them as viable candidates for treating a variety of human diseases and thus warrant attention within the realm of traditional Chinese medicine (TCM). Noni and Red Earthworm have shown efficacy in addressing conditions like osteoporosis, gingivitis, wounds, carcinomas, ulcers, cytotoxicity, nerve regeneration, leishmaniasis, stroke, myocardial ischemia, cardiac fibrosis, and various hematological disorders including the reduction of blood lipids. Despite their potential, their combined application in human and veterinary medicine remains unexplored. However, integrating these sources could offer a promising solution to the escalating challenges of drug resistance and toxicity. This review outlines their pharmacotherapeutic potential and advocates for further research emphasizing the necessity for both in vitro and in vivo evaluations to ascertain the synergistic effects of these agents against important human and animal pathogens.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: